140 related articles for article (PubMed ID: 7850007)
1. Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal aging.
Ghigo E; Ceda GP; Valcavi R; Goffi S; Zini M; Mucci M; Valenti G; Muller EE; Camanni F
Eur J Endocrinol; 1995 Jan; 132(1):32-6. PubMed ID: 7850007
[TBL] [Abstract][Full Text] [Related]
2. Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects.
Arvat E; Gianotti L; Grottoli S; Imbimbo BP; Lenaerts V; Deghenghi R; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1994 Nov; 79(5):1440-3. PubMed ID: 7962341
[TBL] [Abstract][Full Text] [Related]
3. Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjects.
Ghigo E; Ceda GP; Valcavi R; Goffi S; Zini M; Mucci M; Valenti G; Cocchi D; Müller EE; Camanni F
J Endocrinol Invest; 1994 Feb; 17(2):113-7. PubMed ID: 8006330
[TBL] [Abstract][Full Text] [Related]
4. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.
Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F
J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304
[TBL] [Abstract][Full Text] [Related]
5. Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity.
Maccario M; Procopio M; Grottoli S; Oleandri SE; Boffano GM; Taliano M; Camanni F; Ghigo E
Metabolism; 1996 Mar; 45(3):342-6. PubMed ID: 8606641
[TBL] [Abstract][Full Text] [Related]
6. Arginine enhances the growth hormone-releasing activity of a synthetic hexapeptide (GHRP-6) in elderly but not in young subjects after oral administration.
Ghigo E; Arvat E; Rizzi G; Bellone J; Nicolosi M; Boffano GM; Mucci M; Boghen MF; Camanni F
J Endocrinol Invest; 1994 Mar; 17(3):157-62. PubMed ID: 8051337
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.
Valetto MR; Bellone J; Baffoni C; Savio P; Aimaretti G; Gianotti L; Arvat E; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Nov; 135(5):568-72. PubMed ID: 8980159
[TBL] [Abstract][Full Text] [Related]
8. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine.
Procopio M; Maccario M; Grottoli S; Oleandri SE; Boffano GM; Camanni F; Ghigo E
Clin Endocrinol (Oxf); 1995 Dec; 43(6):665-9. PubMed ID: 8736266
[TBL] [Abstract][Full Text] [Related]
9. Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children.
Bellone J; Bartolotta E; Cardinale G; Arvat E; Cherubini V; Aimaretti G; Maccario M; Mucci M; Camanni F; Ghigo E
J Endocrinol Invest; 1993; 16(7):521-5. PubMed ID: 8227981
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone secretion in Alzheimer's disease: studies with growth hormone-releasing hormone alone and combined with pyridostigmine or arginine.
Ghigo E; Nicolosi M; Arvat E; Marcone A; Danelon F; Mucci M; Franceschi M; Smirne S; Camanni F
Dementia; 1993; 4(6):315-20. PubMed ID: 8136894
[TBL] [Abstract][Full Text] [Related]
11. Age-related variations in the neuroendocrine control, more than impaired receptor sensitivity, cause the reduction in the GH-releasing activity of GHRPs in human aging.
Arvat E; Ceda GP; Di Vito L; Ramunni J; Gianotti L; Broglio F; Deghenghi R; Ghigo E
Pituitary; 1998 Apr; 1(1):51-8. PubMed ID: 11081183
[TBL] [Abstract][Full Text] [Related]
12. Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood.
Bellone J; Aimaretti G; Valetto MR; Bellone S; Baffoni C; Arvat E; Seminara S; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Oct; 135(4):421-4. PubMed ID: 8921823
[TBL] [Abstract][Full Text] [Related]
13. Repetitive GHRH administration fails to increase the response to GHRH in obese subjects. Evidence for a somatotrope defect in obesity?
Ghigo E; Procopio M; Maccario M; Bellone J; Arvat E; Campana S; Boghen MF; Camanni F
Horm Metab Res; 1993 Jun; 25(6):305-8. PubMed ID: 8344645
[TBL] [Abstract][Full Text] [Related]
14. GH secretion in Prader-Labhard-Willi syndrome: somatotrope responsiveness to GHRH is enhanced by arginine but not by pyridostigmine.
Beccaria L; Bosio L; Sanzari A; Aimaretti G; Ghigo E; Chiumello G
J Pediatr Endocrinol Metab; 1996; 9(6):577-83. PubMed ID: 9004172
[TBL] [Abstract][Full Text] [Related]
15. Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults.
Ghigo E; Arvat E; Valente F; Nicolosi M; Boffano GM; Procopio M; Bellone J; Maccario M; Mazza E; Camanni F
Neuroendocrinology; 1991 Sep; 54(3):291-4. PubMed ID: 1944815
[TBL] [Abstract][Full Text] [Related]
16. Arginine abolishes the inhibitory effect of glucose on the growth hormone response to growth hormone-releasing hormone in man.
Ghigo E; Miola C; Aimaretti G; Valente F; Procopio M; Arvat E; Yin-Zhang W; Camanni F
Metabolism; 1992 Sep; 41(9):1000-3. PubMed ID: 1355580
[TBL] [Abstract][Full Text] [Related]
17. Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients.
Grottoli S; Razzore P; Arvat E; Oleandri SE; Rossetto R; Ciccarelli E; Camanni F; Ghigo E
J Endocrinol Invest; 1997 Nov; 20(10):597-602. PubMed ID: 9438917
[TBL] [Abstract][Full Text] [Related]
18. Further evidence of cholinergic impairment of the neuroendocrine control of the GH secretion in Down's syndrome.
Beccaria L; Marziani E; Manzoni P; Arvat E; Valetto MR; Gianotti L; Ghigo E; Chiumello G
Dement Geriatr Cogn Disord; 1998; 9(2):78-81. PubMed ID: 9524798
[TBL] [Abstract][Full Text] [Related]
19. The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man.
Giustina A; Bossoni S; Bodini C; Doga M; Girelli A; Buffoli MG; Schettino M; Wehrenberg WB
Metabolism; 1991 May; 40(5):519-23. PubMed ID: 2023538
[TBL] [Abstract][Full Text] [Related]
20. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
